From the Toronto Star:
Next week, the United States Food and Drug Administration will hold a highly unusual three-day hearing into the benefits and risks of the class of drugs called COX-2 inhibitors.
The hearing follows a bizarre few months in which Vioxx, one of the drugs used widely by arthritis sufferers for pain, was pulled from the market worldwide and two other widely prescribed drugs, Celebrex and Bextra, have come under growing suspicion. more...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment